Acella Pharmaceuticals, LLC v. Chemo S.A. France
2:13-cv-00573
Overview
Parties
Defendant
Chemo S.A. France NPE (Individual / Inventor)
Represented By
2 Attorneys ListedSheppard Mullin Richter & Hampton LLP
1300 I Street NW, 11th Floor East
Sheppard Mullin Richter & Hampton LLP
1300 I Street NW, 11th Floor East
Plaintiff
Acella Pharmaceuticals, LLC Operating Company
Represented By
4 Attorneys ListedNelson Mullins Riley & Scarborough LLP (DC)
101 Constitution Avenue, NW, Suite 900
Nelson Mullins Riley & Scarborough
Nelson Mullins Riley & Scarborough, Poinsett Plaza
Nelson Mullins Riley & Scarborough
Nelson Mullins Riley & Scarborough, Poinsett Plaza
Polsinelli PC
1401 Eye Street, NW, Suite 800
Court & Judges
Court
District Court, E.D. Virginia (vaed)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Westminster Pharmaceuticals, LLC v. Chemo S.A. France, now known as LPRI France et al.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8183227
Compositions, kits and methods for nutrition supplementation
|
Filed: 2011-11-09
Issued: 2012-05-22
|
Active (5.0 yrs remaining)
Expires: 2031-11-09
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
19
Dispositive
10
Granted
1
Denied
0
Pending / Review
18
Motions by Category
Key Dispositive Motions & Rulings